Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
-0.50%
Price
18:36
€21.79
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by -0.50%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.668% | 1.668% |
| iShares Core DAX® | 2.462% | 4.579% |
| iShares Nasdaq 100 | 1.237% | -0.442% |
| iShares Nikkei 225® | 2.933% | 1.229% |
| iShares S&P 500 | 0.975% | 0.565% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat